FDMT SCHEDULE 13G/A: SEC filing

Biotechnology Value Fund and affiliated entities

Filed with the SEC on · accession 0000921895-26-003177

FDMT filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -7.7% by the first close after the filing.

Summary of the filing

Biotechnology Value Fund and affiliated entities filed an amended Schedule 13G disclosing beneficial ownership of approximately 9.99% of 4D Molecular Therapeutics' common stock, including shares underlying pre-funded warrants subject to a 9.99% blocker.

Key details

Shares beneficially owned by BVF Partners L.P. (aggregate)$5.8M
Shares beneficially owned by Biotechnology Value Fund, L.P.$4.3M
Shares underlying Pre-Funded Warrants held by Reporting Persons$7.5M
Reporting person / beneficial ownerBiotechnology Value Fund, L.P.
Investment manager / reporting personBVF Partners L.P.
Subject company4D Molecular Therapeutics, Inc.
Director and officer of bvf inc.Mark N. Lampert

How FDMT stock reacted

Close before

$12.23

Nov 13, 2026

First close after

-7.69%

$11.29

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for FDMT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for FDMT?

Click here

Frequently asked questions

What did FDMT file with the SEC on Nov 16, 2026?

FDMT filed a SCHEDULE 13G/A (SEC filing). Biotechnology Value Fund and affiliated entities filed an amended Schedule 13G disclosing beneficial ownership of approximately 9.99% of 4D Molecular Therapeutics' common stock, including shares underlying pre-funded warrants subject to a 9.99% blocker.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did FDMT stock react to this filing?

FDMT closed at $12.23 before the filing and $11.29 on Nov 16, 2026 (-7.69%).

Other FDMT SEC filings

Get alerts when FDMT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days